During the past decade, Biotrial conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 7 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Biotrial" #1 sponsor was "Bial - Portela C S.A." with 10 trials, followed by "Alios Biopharma Inc." with 4 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 2 trials sponsored and "Institut Pasteur" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Biotrial" #1 collaborator was "Biotrial" with 3 trials as a collaborator, "Alexion" with 1 trials as a collaborator, "Janssen Pharmaceutica" with 1 trials as a collaborator and "Vertex Pharmaceuticals Incorporated" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Biotrial" are "Parkinson Disease" (4 trials), "Healthy Subjects" (3 trials), "Hypertension" (3 trials), "Chronic Heart Failure" (2 trials) and "Chronic Hepatitis C" (2 trials). Many other conditions were trialed in "Biotrial" in a lesser frequency.

Most popular intervention types in "Biotrial" are "Drug" (25 trials), "Other" (5 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "BIA 9-1067" (5 trials), "BIA 5-453" (3 trials), "AL-335" (2 trials) and "elafibranor" (2 trials). Other intervention names were less common.

The vast majority of trials in "Biotrial" are 21 trials for "All" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Biotrial". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Biotrial, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Biotrial, 25 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".